InsiderClue
Insiders · Profile

Tak Paul Peter

Chief Executive Officer at Candel Therapeutics. Filing since 29 Jul 2021. CIK 0001873905

Company
Date
Role
Action
Shares
Amount
Of holding
CADL Candel Therapeutics, Inc.
11 Sep 2026
Chief Executive Officer
Sold on a plan
59,379
$620.89K
34.4%
CADL Candel Therapeutics, Inc.
10 Sep 2026
Chief Executive Officer
Sold on a plan
220,866
$2.54M
56.1%
CADL Candel Therapeutics, Inc.
19 Mar 2025
Chief Executive Officer
Sold on a plan
400
$3.60K
0.2%
CADL Candel Therapeutics, Inc.
18 Mar 2025
Chief Executive Officer
Sold on a plan
25,772
$226.02K
10.2%
CADL Candel Therapeutics, Inc.
15 Jan 2025
Chief Executive Officer
Sold at will
21,704
$156.81K
7.9%
CADL Candel Therapeutics, Inc.
8 Jan 2025
Chief Executive Officer
Sold at will
21,172
$174.00K
7.2%
CADL Candel Therapeutics, Inc.
29 Nov 2024
Chief Executive Officer
Sold at will
48,847
$222.53K
14.2%
CADL Candel Therapeutics, Inc.
17 Jul 2024
Chief Executive Officer
Sold at will
22,528
$145.81K
6.4%
CADL Candel Therapeutics, Inc.
11 Jul 2024
Chief Executive Officer
Sold at will
20,293
$121.22K
5.4%
CADL Candel Therapeutics, Inc.
9 Dec 2022
Chief Executive Officer
Bought
12,935
$24.84K
46.1%
CADL Candel Therapeutics, Inc.
8 Dec 2022
Chief Executive Officer
Bought
3,050
$5.19K
12.2%
CADL Candel Therapeutics, Inc.
29 Jul 2021
Chief Executive Officer
Bought
25,000
$200.00K
opened
12 decisions on file.